State strategies to address medicaid prescription spending: negotiated pricing vs price transparency
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Noh, Shihyun | - |
dc.contributor.author | Janousek, Christian L. | - |
dc.contributor.author | Park, Ji Hyung | - |
dc.date.accessioned | 2021-09-08T07:40:54Z | - |
dc.date.available | 2021-09-08T07:40:54Z | - |
dc.date.created | 2021-07-15 | - |
dc.date.issued | 2021-04 | - |
dc.identifier.issn | 1744-1331 | - |
dc.identifier.uri | http://scholarworks.bwise.kr/ssu/handle/2018.sw.ssu/41182 | - |
dc.description.abstract | This research longitudinally examines the association between levels of state Medicaid prescription spending and the state strategies intended to constrain cost increases: the negotiated pricing strategy, as indicated by state rebate programs, and the price transparency strategy, as indicated by state operation of All-Payer Claims Databases. The findings demonstrate evidence that state Medicaid prescription spending is influenced by the negotiated pricing strategy, especially Managed Care Organization (MCO) rebates under the Patient Protection and Affordable Care Act, but not influenced by the price transparency strategy. State decisions for MCO rebates, such as carving prescription benefits into managed care benefits, were effective in containing levels of Medicaid prescription spending over time, while other single- and multi-state rebate programs were not. Based on these findings, state policymakers may consider utilizing the MCO rebate program to address increases in Medicaid prescription spending. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | CAMBRIDGE UNIV PRESS | - |
dc.relation.isPartOf | HEALTH ECONOMICS POLICY AND LAW | - |
dc.title | State strategies to address medicaid prescription spending: negotiated pricing vs price transparency | - |
dc.type | Article | - |
dc.identifier.doi | 10.1017/S1744133120000080 | - |
dc.type.rims | ART | - |
dc.identifier.bibliographicCitation | HEALTH ECONOMICS POLICY AND LAW, v.16, no.2, pp.201 - 215 | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000631421400007 | - |
dc.citation.endPage | 215 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 201 | - |
dc.citation.title | HEALTH ECONOMICS POLICY AND LAW | - |
dc.citation.volume | 16 | - |
dc.contributor.affiliatedAuthor | Park, Ji Hyung | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.subject.keywordAuthor | Affordable Care Act | - |
dc.subject.keywordAuthor | All payer claims databases | - |
dc.subject.keywordAuthor | Medicaid prescription spending | - |
dc.subject.keywordAuthor | Negotiated pricing | - |
dc.subject.keywordAuthor | Price transparency | - |
dc.relation.journalResearchArea | Health Care Sciences & Services | - |
dc.relation.journalWebOfScienceCategory | Health Policy & Services | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Soongsil University Library 369 Sangdo-Ro, Dongjak-Gu, Seoul, Korea (06978)02-820-0733
COPYRIGHT ⓒ SOONGSIL UNIVERSITY, ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.